Vincent Gregoire
Overview
Explore the profile of Vincent Gregoire including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
241
Citations
5612
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ludwig R, Werlen S, Barbatei D, Widmer L, Pouymayou B, Balermpas P, et al.
Radiother Oncol
. 2024 Aug;
200:110474.
PMID: 39128626
Aim: Whereas the prevalence of lymph node level (LNL) involvement in oral cavity squamous cell carcinomas (OCSCC) has been reported, the details of lymphatic progression patterns are insufficiently quantified. We...
2.
Ludwig R, Schubert A, Barbatei D, Bauwens L, Hoffmann J, Werlen S, et al.
Sci Rep
. 2024 Jul;
14(1):15750.
PMID: 38977731
The elective clinical target volume (CTV-N) in oropharyngeal squamous cell carcinoma (OPSCC) is currently based mostly on the prevalence of lymph node metastases in different lymph node levels (LNLs) for...
3.
Mazzoni L, Damilakis J, Guen B, Haghdoost S, Rottger A, Siiskonen T, et al.
Phys Med
. 2024 Jun;
124:103392.
PMID: 38862325
The International Commission on Radiological Protection (ICRP), recently expressed concern that "a shortage of investment in training, education, research, and infrastructure seen in many sectors and countries may compromise society's...
4.
Grau C, Dasu A, Troost E, Haustermans K, Weber D, Langendijk J, et al.
Radiother Oncol
. 2024 Apr;
196:110293.
PMID: 38653379
The evidence for the value of particle therapy (PT) is still sparse. While randomized trials remain a cornerstone for robust comparisons with photon-based radiotherapy, data registries collecting real-world data can...
5.
Machiels J, Tao Y, Licitra L, Burtness B, Tahara M, Rischin D, et al.
Lancet Oncol
. 2024 Apr;
25(5):572-587.
PMID: 38561010
Background: Despite multimodal therapy, 5-year overall survival for locally advanced head and neck squamous cell carcinoma (HNSCC) is about 50%. We assessed the addition of pembrolizumab to concurrent chemoradiotherapy for...
6.
Benzazon N, Carre A, de Kermenguy F, Niyoteka S, Maury P, Colnot J, et al.
Int J Radiat Oncol Biol Phys
. 2024 Mar;
120(1):253-264.
PMID: 38554830
Purpose: The dose deposited outside of the treatment field during external photon beam radiation therapy treatment, also known as out-of-field dose, is the subject of extensive study as it may...
7.
Morel D, Robert C, Paragios N, Gregoire V, Deutsch E
Clin Cancer Res
. 2024 Mar;
30(11):2317-2332.
PMID: 38477824
Ionizing radiation can have a wide range of impacts on tumor-immune interactions, which are being studied with the greatest interest and at an accelerating pace by the medical community. Despite...
8.
Taylor K, Amdal C, Bjordal K, Astrup G, Herlofson B, Duprez F, et al.
Int J Cancer
. 2024 Feb;
154(10):1772-1785.
PMID: 38312044
Head and neck cancer (HNC) patients suffer from a range of health-related quality of life (HRQoL) issues, but little is known about their long-term HRQoL. This study explored associations between...
9.
Ludwig R, Schubert A, Barbatei D, Bauwens L, Werlen S, Elicin O, et al.
Data Brief
. 2024 Jan;
52:110020.
PMID: 38293584
Dataset: We provide a dataset on lymph node metastases in 968 patients with newly diagnosed head and neck squamous cell carcinoma (HNSCC). All patients received neck dissection and we report...
10.
Mortensen H, Populaire P, Hoffmann L, Moeller D, Appelt A, Nafteux P, et al.
Radiother Oncol
. 2023 Nov;
190:109980.
PMID: 37935284
No abstract available.